Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
作者信息
McAlack R F, Stern S, Beizer R, Sklar L, Bannett A
出版信息
Transplant Proc. 1979 Jun;11(2):1431-2.
PMID:382532
Abstract
摘要
相似文献
1
Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.接受抗淋巴细胞球蛋白（ALG）治疗与未接受ALG治疗的肾移植患者的免疫监测参数。
Transplant Proc. 1979 Jun;11(2):1431-2.
2
Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
Transplant Proc. 1987 Feb;19(1 Pt 3):1874-8.
3
4
Monitoring and modulation of recipient immune responsiveness to prevent kidney graft rejection in the early post-transplant period.监测和调节受体免疫反应性以预防移植后早期肾移植排斥反应。
Proc Eur Dial Transplant Assoc. 1977;14:336-41.
5
In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
Proc Clin Dial Transplant Forum. 1978;8:56-61.
6
Antirejection treatment with anti-thymocyte globulin in renal transplant recipients treated with cyclosporine as basic immunosuppression.在以环孢素作为基础免疫抑制治疗的肾移植受者中，使用抗胸腺细胞球蛋白进行抗排斥治疗。
Transplant Proc. 1988 Oct;20(5 Suppl 6):12-3.
7
[Evaluation of the effectiveness of ALG in clinical kidney transplantation in alternating studies].[在交替研究中评估抗淋巴细胞球蛋白（ALG）在临床肾移植中的有效性]
Chir Forum Exp Klin Forsch. 1979:325-8.
8
Rapid T cell recovery after prophylactic ALG is associated with pancreas allograft rejection.预防性抗淋巴细胞球蛋白治疗后T细胞的快速恢复与胰腺同种异体移植排斥反应相关。
Transplant Proc. 1990 Apr;22(2):619.
9
Renal transplantation (second of two parts).肾移植（两部分中的第二部分）
N Engl J Med. 1979 Nov 8;301(19):1038-48. doi: 10.1056/NEJM197911083011905.
10
The effect of induction ALG (MALG) on the outcome of steroid-resistant rejection treated with OKT3 in renal transplant patients.
Transplant Proc. 1991 Feb;23(1 Pt 2):1039-40.
Zotero 插件